Institutional investors purchased a net $1.5 million shares of RGEN during the quarter ended December 2015 and now own 87.92% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONESTOGA CAPITAL ADVISORS LLC Bought 227.8 Thousand shares of Repligen Corp
RUSSELL INVESTMENT MANAGEMENT CO... Bought 27.7 Thousand shares of Repligen Corp
PALO CAPITAL, INC. Bought 7.8 Thousand shares of Repligen Corp